GGrantIndex
Sort

64,565 grants matching drug discovery

Creation of a New Penn State Zebrafish Functional Genomics Core

$476,191
Keith Chi Cheng · Pennsylvania State Univ Hershey Med Ctr · G20 · FY2013 · OD

Preclinical Validation of PPARg Acetylation Inhibitors for Diabetes Prevention and Treatment

$476,180
Weidong Wang · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2021 · DK

Genes Contributing to Opioid Abuse in Humans

$476,162
Kari Stefansson · Decode Genetics, Ehf · R01 · FY2010 · DA

Single Cell Sampling of Signaling Activity in Triple Negative Breast Cancer

$476,069
David S. Lawrence · Univ Of North Carolina Chapel Hill · R01 · FY2019 · CA

Preclinical development of a selective Orexin-1 receptor antagonist for treatment of cocaine addiction

$476,025
Craig Fox · C4x Discovery Ltd · R01 · FY2018 · DA

ApoE4-targeted therapeutics that normalize SirT1

$476,014
Varghese John · University Of California Los Angeles · R01 · FY2016 · AG

RESEARCH EDUCATION PROGRAM IN ASPECTS OF STATISTICAL GENETICS AND ADDICTION

$475,924
Pamela Ann Madden · Washington University · R25 · FY2010 · DA

Novel Neurotensin Analogs as Antischizophrenics

$475,884
Argolyn Bioscience, Inc. · R44 · FY2005 · MH

Advanced Development and Validation of 3 Dimensional Spheroid Culture of Primary Cancer Cells using Nano3D Technology

$475,865
Timothy Patrick Spicer · Scripps Florida · R33 · FY2017 · CA

Identification of Pathways that can be Targeted for the Development of Novel Therapies for MRSA

$475,797
Eleftherios Mylonakis · Massachusetts Eye And Ear Infirmary · P01 · FY2014 · AI

Chemical Probes for Metabolic Pathway Discovery in Human Disease

$475,796
Benjamin F Cravatt · Scripps Research Institute, The · R01 · FY2017 · CA

Chemical Probes for Metabolic Pathway Discovery in Human Disease

$475,796
Benjamin F Cravatt · Scripps Research Institute, The · R01 · FY2018 · CA

The Autism Sequencing Consortium: Autism Gene Discovery in >50,000 Exomes

$475,793
Mark J Daly · Broad Institute, Inc. · U01 · FY2017 · MH

Drug Discovery for First-In-Class Myosin 10 Inhibitors as a Novel Target for Glioblastoma

$475,793
Courtney A Miller · University Of Florida · R33 · FY2024 · NS

Prefrontal circuits controlling heroin seeking

$475,771
Jamie L Peters · University Of Alabama At Birmingham · R01 · FY2025 · DA

Targeting DNA repair in KRAS mutated lung cancer by chemical screening

$475,767
You-Wei Zhang · Case Western Reserve University · R01 · FY2023 · CA

Targeting DNA repair in KRAS mutated lung cancer by chemical screening

$475,767
You-Wei Zhang · Case Western Reserve University · R01 · FY2022 · CA

Molecular Basis of Noonan Syndrome and Related Disorder

$475,742
Bruce D Gelb · Icahn School Of Medicine At Mount Sinai · R01 · FY2013 · HL

Exploring Novel Targeting Strategies for AIDS Protozoal Pathogens

$475,737
Karen S Anderson · Yale University · R01 · FY2015 · AI

Phenotypic Assay Design and Development for Rare and Neglected Diseases

$475,656
James Inglese · National Center For Advancing Translational Sciences · ZIA · FY2020 · TR

Human genetics and molecular mechanisms of Vein of Galen aneurysmal malformation

$475,627
Kristopher Kahle · Massachusetts General Hospital · R01 · FY2021 · NS

Live-Cell Assays for Lysosomal Enzyme Activity

$475,627
John J Naleway · Marker Gene Technologies · R44 · FY2014 · NS

Novel Protein Engineered Drug Conjugates Targeting Phosphatidylserine for the Treatment of Breast Cancer

$475,608
Kevin G Pinney · Baylor University · R01 · FY2021 · CA

Training of Academic Gynecologic Oncologists

$475,582
Karen Hsieh Lu · University Of Tx Md Anderson Can Ctr · T32 · FY2020 · CA

HDACs in Neurodegeneration and Aging

$475,565
Lisa M. Ellerby · Buck Institute For Research On Aging · RL1 · FY2010 · NS